Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata

International Journal of Trichology

Volumn 3, Issue 1, 2011, Pages 20-24

  Kuldeep, C M ^a   Singhal, Himanshu ^a   Khare, Ashok K ^a   Mittal, Asit ^a   Gupta, Lalit K ^a   Garg, Anubhav ^a  

^a RNT MEDICAL COLLEGE   (India)

Author keywords

Alopecia areata; betamethasone valerate foam; tacrolimus; triamcinolone acetonide

Indexed keywords

EID: 81255194131     PISSN: 09747753     EISSN: 09749241     Source Type: Journal    
DOI: 10.4103/0974-7753.82123     Document Type: Article

References (30)

1. Anderson I. Alopecia areata: A clinical study. Br Med J 1950;2:1250-2.
2. th ed. Massachusetts: Blackwell Publishers; 2004. p. 63.36-63.46.
3. Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int J Dermatol 1996;35:22-7.
4. Safavi K. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol 1992;128:702.
5. Van der Steen P, Troupe H, Happle R, Boenzeman J, Strater R, Hamm H. The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate. Acta Derm Venereol 1992;72:373-5.
6. Aita VM, Christiano AM. The genetics of alopecia areata. Dermatol Ther 2001;14:329-39.
7. Hendren OS. Identical alopecia in identical twins. Arch Derm Syphilol 1949;60:793-5.
8. Freidman PS. Alopecia areata and auto-immunity. Br J Dermatol 1981;105:153-7.
9. McDonagh AJ, Messenger AG. The pathogenesis of alopecia areata. Dermatol Clin 1996;14:661-70.
10. Sullivan SR, Kossard S. Acquired scalp alopecia. Part 2: A review. Aust J Dermatol 1999;40:61-72.
11. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-66.
12. Ikeda T. A new classification of alopecia areata. Dermatologica 1965;131:421-45.
13. Fielder VC. Alopecia areata: A review of therapy, efficacy, safety and mechanism. Arch Dermaol 1992;128:1519-29.
14. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG. Guide lines for the management of alopecia areata. Br J Dermatol 2003;149:692-99.
15. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008;2:CD004413.
16. Bolduc C, Lui H, Shapiro J. Alopecia areata treatment and medication. Available from: http://e-medicinemedscape.com/article 1069931 [Last accessed on 19 April, 2009]
17. Harries MJ, Sun J, Paus R, King LE. Management of alopecia areata: Clinical review. Br Med J 2010;341:242-6.
18. Sawaya ME, Hordinsky MK. Glucocorticoid regulation of hair growth in alopecia areata. J Invest Dermatol 1995;194:30.
19. Mancuso G, Balducci A, Casadio C, Farina P, Staffa M, Valenti L, et al. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in treatment of mild to moderate alopecia areata: multicentric, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol 2003;42;572-5.
20. Tosti A, Iorizzo M, Botta GL, Milani M. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized double blind placebo controlled trial. J Euro Acad Dermatol Venereol 2006;20:1243-7.
21. Prescriber update. Topical steroids and skin damage. WHO Drug Inf Bull 2006;20:1.
22. Porter D, Burton JL. Comparison of intralesional triamcinolone hexa-cetonide and triacinolone acetonide in alopecia areata. Br J Dermatol 1971;85:272-3.
23. Abell E, Munro DD. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol 1973;88:55-9.
24. Kubeyinje E P. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs. East Afr Med 1994;71:674-5.
25. Sainbury TS, Duncon JI, Whiting PH, Hewick DS, Johnson BE, Thompson AW et al. Differential effects of FK-506 and cyclosporine on hair re-growth in DEBR model for AA. Transplant Proc.1991; 23: 3332-4.
26. Hooks MA. Tacrolimus. A new immune-suppressant: A review of the literature. Ann Pharmacother 1994;28:501-11.
27. Price H V, Willey A, Chen BK. Topical tacrolimus in alopecia areata. J Am Acad Dermatol 2005;52:138-9
28. Thiers BH. Topical tacrolimus: Treatment failure in a patient with AA. Arch Dermatol 2000;136:124.
29. Park S W, Kim J W, Wang H Y. Topical tacrolimus (FK506); treatment failure in 4 cases of alopecia universalis. Acta Derm Venereol 2002;82;387-8
30. Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, et al. Alopecia areata investigational assessment guidelines-part2. National Alopecia Areata Foundation. J Am Acad Dermatol 2004;51:440-7.